These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25368806)

  • 1. Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans.
    Zarei Mahmoudabadi A; Zarrin M; Kiasat N
    Jundishapur J Microbiol; 2014 Jul; 7(7):e17105. PubMed ID: 25368806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-biofilm properties of eucalyptol in combination with antifungals against Candida albicans isolates in patients with hematological malignancy.
    Keymaram M; Falahati M; Farahyar S; Lotfali E; Abolghasemi S; Mahmoudi S; Sadeghi F; Khalandi H; Ghasemi R; Shamsaei S; Raiesi O
    Arch Microbiol; 2022 May; 204(6):295. PubMed ID: 35508567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biofilm-forming capacity of blood-borne Candida albicans strains and effects of antifungal agents.
    Turan H; Demirbilek M
    Rev Argent Microbiol; 2018; 50(1):62-69. PubMed ID: 28988900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigation of the correlation between biofilm forming ability of urinary Candida isolates with the use of urinary catheters and change of antifungal susceptibility in the presence of biofilm].
    Aslan H; Gülmez D
    Mikrobiyol Bul; 2016 Apr; 50(2):256-65. PubMed ID: 27175498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
    Nagy F; Tóth Z; Bozó A; Czeglédi A; Rebenku I; Majoros L; Kovács R
    Med Mycol; 2019 Jul; 57(5):573-581. PubMed ID: 30339227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms.
    Luiz RL; Vila TV; de Mello JC; Nakamura CV; Rozental S; Ishida K
    BMC Complement Altern Med; 2015 Mar; 15():68. PubMed ID: 25886244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibility testing of Candida tropicalis biofilms against fluconazole using calorimetric indicator resazurin.
    Punithavathy PM; Nalina K; Menon T
    Indian J Pathol Microbiol; 2012; 55(1):72-4. PubMed ID: 22499305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
    Katragkou A; McCarthy M; Alexander EL; Antachopoulos C; Meletiadis J; Jabra-Rizk MA; Petraitis V; Roilides E; Walsh TJ
    J Antimicrob Chemother; 2015 Feb; 70(2):470-8. PubMed ID: 25288679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.
    Kraft L; Ribeiro VST; Gonçalves GA; Suss PH; Tuon FF
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Dec; 41(10):596-603. PubMed ID: 36707288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.
    Nett J; Lincoln L; Marchillo K; Massey R; Holoyda K; Hoff B; VanHandel M; Andes D
    Antimicrob Agents Chemother; 2007 Feb; 51(2):510-20. PubMed ID: 17130296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.
    Melo AS; Bizerra FC; Freymüller E; Arthington-Skaggs BA; Colombo AL
    Med Mycol; 2011 Apr; 49(3):253-62. PubMed ID: 21039308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry.
    Maiolo EM; Furustrand Tafin U; Borens O; Trampuz A
    Antimicrob Agents Chemother; 2014 May; 58(5):2709-17. PubMed ID: 24566186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
    Demirbileki M; Timurkaynak F; Can F; Azap O; Arslan H
    Mikrobiyol Bul; 2007 Apr; 41(2):261-9. PubMed ID: 17682713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine A decreases the fluconazole minimum inhibitory concentration of Candida albicans clinical isolates but not biofilm formation and cell growth.
    Wibawa T; Nurrokhman ; Baly I; Daeli PR; Kartasasmita G; Wijayanti N
    Trop Biomed; 2015 Mar; 32(1):176-82. PubMed ID: 25801268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms.
    Khan MS; Ahmad I
    J Antimicrob Chemother; 2012 Mar; 67(3):618-21. PubMed ID: 22167241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
    Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
    Kawai A; Yamagishi Y; Mikamo H
    J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.